• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC. MILOOP LENS FRAGMENTATION DEVICE; OPHTHALMIC HOOK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC. MILOOP LENS FRAGMENTATION DEVICE; OPHTHALMIC HOOK Back to Search Results
Model Number FG-11881
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Vitreous Loss (2142); Capsular Bag Tear (2639); Vitrectomy (2643)
Event Date 03/13/2019
Event Type  Injury  
Manufacturer Narrative
The device was discarded by the user facility and is not available for evaluation.The device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling.The relationship between the event and the device is unknown and no surgical video is available for analysis.Capsular bag damage and vitreous loss are inherent risks of cataract surgery.Manufacturer's reference #: (b)(4).
 
Event Description
A (b)(6) year-old female patient with a grade 3+ nuclear sclerotic cataract underwent cataract surgery on (b)(6) 2019 where the miloop device was used to section the cataractous lens into quadrants.After the first successful bisection, the surgeon removed the miloop from the eye, rotated the lens with a drysdale nucleus manipulator (storz), then reinserted the miloop and made the final lens cut.After removing the first 2 lens quadrants, the surgeon noticed a small posterior capsule tear at the 9:00 position (left eye, temporal incision) and vitreous loss.A vitrectomy was performed and a sulcus-fixated intraocular lens was implanted.Additional information has been requested.
 
Manufacturer Narrative
Manufacturer's reference #: (b)(4).
 
Event Description
Patient follow-up information was requested from the surgeon and the clinic reported that the patient's bcva in the operative eye was 20/20-2 at last examination on (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MILOOP LENS FRAGMENTATION DEVICE
Type of Device
OPHTHALMIC HOOK
Manufacturer (Section D)
CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
8748 technology way
reno NV 89521
MDR Report Key8452743
MDR Text Key139878948
Report Number3012123033-2019-00003
Device Sequence Number1
Product Code HNQ
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 05/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/26/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/12/2021
Device Model NumberFG-11881
Device Lot NumberFG20180514-20
Was Device Available for Evaluation? No
Date Manufacturer Received04/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DRYSDALE NUCLEUS MANIPULATOR (STORZ); DRYSDALE NUCLEUS MANIPULATOR (STORZ)
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-